What Researchers Did
This review article explored the current knowledge and experience regarding ozone and oxidation therapies as potential solutions for managing emerging infectious diseases.
What They Found
The review highlights that ozone therapy, a germicide rather than an antibiotic, has shown an extremely high safety profile with minimal reported side effects beyond vein irritation. It also notes that Ebola, for example, has a 65% mortality rate and has caused over 2000 deaths, with recent reports indicating favorable responses to ozone therapy for both bacterial and viral diseases.
What This Means for Canadian Patients
Canadian patients facing antibiotic-resistant infections or emerging viral threats might benefit from further research into adjunctive or alternative therapies like ozone. While not currently a standard treatment, this review suggests exploring non-patentable, inexpensive options could be valuable in managing difficult-to-treat infections.
Canadian Relevance
This study has no direct Canadian connection as it is a general review of global infectious disease challenges and potential therapies.
Study Limitations
As a review, this study synthesizes existing literature and does not present new primary research or clinical trial data on the efficacy of ozone therapy.